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Background: With the growing number of elderly population in Taiwan and many other countries, the
role of metabolic syndrome (MetS) has become more important recently. Although had been reported in
different age groups, the relationship between platelet and MetS in the geriatric population still remains
unknown.
Methods: We included 1187 Taiwanese males who were older than 65 years. In this study, we excluded
individuals with abnormal platelet counts to reveal a more clear relation between platelet counts and
MetS. Platelet counts were analyzed among patients with and without MetS. We divided platelet counts
into four groups according to quartiles arbitrary of platelet counts (lowest, PC1; highest, PC4). The
number of MetS components was compared between platelet groups with analysis of variance. We also
used simple correlation and multivariate linear regression to ﬁnd the relationship between platelet
counts and MetS components.
Results: We found that the platelet counts were higher in the group with MetS but not signiﬁcantly
different (p ¼ 0.675). The fasting plasma glucose (FPG), total cholesterol, low-density lipoprotein-
cholesterol (LDL-C), triglyceride (TG), and Log-triglyceride (Log-TG) were all statistically different across
the four platelet groups. These four components were also positively correlated to platelet count in
simple correlation. Not surprisingly, FPG, LDL-C, TG, and Log-TG were positively correlated with platelet
count in multivariate linear regression.
Conclusion: FPG, LDL-C, TG, and Log-TG were positively correlated with platelet count among the MetS
components in geriatric Taiwanese males. The role of HDL-C and LDL-C in the deﬁnition of MetS should
be re-evaluated.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
As early as in 1966, the concept of metabolic syndrome (MetS)
was ﬁrst brought out by Avogaro et al1. Soon, in 1988, Reaven2
coined the term “syndrome X” to describe this clustering andterest.
ent of Pathology, National
, Tri-Service General Hospital,
ROC.
iwan Society of Geriatric Emergensuggested that insulin resistance is the core of these risk factors.
During the same period of time, the prevalence of cardiovascular
disease (CVD) and diabetes was increasing in an alarming rate all
over the world3e6. Under this circumstance, the World Health
Organization (WHO) recognized the seriousness of this problem
and recommended a unifying deﬁnition; it was the ﬁrst to intro-
duce the term “metabolic syndrome” in the hope to detect people
at risk for CVD and diabetes in advance7. Following WHO, many
other organizations proposed their own deﬁnitions in order to ﬁt
the heterogeneities between different ethnic groups. At present,
the most commonly used deﬁnition is the one proposed by the
National Cholesterol Education Program, Adult Treatment Panel IIIcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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WHO criteria8. Ever since these deﬁnitions had been published,
a wide range of studies had been conducted, such as evaluation of
the predictability and the underlying pathophysiology of MetS,
etc9e11.
It was about the same time that the role of inﬂammatory
markers in CVD was recognized and evaluated12,13. These inﬂam-
matory markers were found to be related not only to CVD but also
to MetS14e17. Among all different inﬂammatory markers, c-reactive
protein (CRP), interleukin-6, and tumor necrosis factor-a were the
most commonly studied ones18,19. Compared to these markers,
althoughwhite blood cell count (WBCC) has a less important role, it
was the ﬁrst one to be recognized as a risk factor for myocardial
infarction3e6 and also to be correlated with MetS7,15,20e22. Other
than WBCC, surprisingly, platelet count (PC) was also found to be
higher in individuals with MetS3e10. This relationship could be
explained by its ability to modulate inﬂammation through
releasing cytokines and to mediate the interaction with leuko-
cytes23. Although several studies reported the role of PC in MetS
in adults, only limited information could be found in case of
geriatric males. Since the proportion of aged people is increasing
in Taiwan as well as in many other countries, early detection of
MetS among these people is becoming a major public health
concern. In this study, we examined the correlations between PC
and MetS in elderly males in order to shed light on this important
relationship.Table 1
Participant characteristics (mean  SD).
MetS (e) MetS (þ) p
Number 886 301
Age (y) 70.3  4.5 70.2  4.4 0.000
BMI (kg/m2) 18.9  2.5 20.6  2.4 0.000
SBP (mmHg) 131.67  20.5 144.9  19.7 0.000
DBP (mmHg) 74.5  11.6 80.9  11.1 0.000
FPG (mmol/L) 101.6  22.1 119.6  35.9 0.000
TC (mmol/L) 203.1  37.9 208.1  40.3 0.054
HDL-C (mmol/L) 49.5  13.5 36.1  9.8 0.000
LDL-C (mmol/L) 133.4  33.6 135.0  36.1 0.490
TG (mmol/L) 101.1  42.9 185.4  72.1 0.000
Log-TG 2.0  0.2 2.2  0.2 0.000
PC (10  109 cells/L) 203.7  54.2 205.2  51.7 0.675
BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose;
HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein
cholesterol; Log-TG ¼ log transformation of triglyceride; SBP ¼ systolic blood
pressure; SD ¼ standard deviation; TC ¼ total cholesterol; TG ¼ triglyceride.2. Methods
2.1. Study participants
In this cross-sectional study, we enrolled males older than 65
years from individuals receiving annual health examination at the
M J Life Clinic in Taiwan. The M J Life Clinics are private clinics and
provide regular health examinations in north, central, and south
Taiwan.
Inclusion criterion was men over 65 years old. However,
patients with major medical diseases, those known to have dia-
betes, or those under medication for hyperlipidemia, hyperten-
sion or diabetics were excluded. Using any medications for those
diseases would apparently decrease the true values of blood
pressure (BP), lipids, and blood glucose, and thus prohibit our
further analysis of the MetS components. Since we wanted to
evaluate the relationships more precisely, we included individuals
with normal level of PC only. After the preliminary screening, 1233
patients were enrolled. We further excluded two patients with
abnormal PC and 33 with missing data. Finally, 1187 participants
were analyzed.
The MetS deﬁnition of the NECP ATP III was used in this study24.
However, instead of using waist circumferences, body mass index
(BMI) was used because the data were not available. The use of BMI
could be justiﬁed by Lee’s study10. For Chinese people, BMI26.4 in
male is equivalent to waist circumference 90 cm.
Participants visited the clinic at 8:00 after fasting for at least 10
hours. Senior nursing staffs obtained the information on medical
history, lifestyle, alcohol intake, smoking, and physical exercise. A
complete physical examination was done and BMI was calculated
as weight/height2 (kg/m2). The participants were required to rest
for at least 5 minutes before the nursing staff measured the BP
using a standard mercury sphygmomanometer on the right arm in
seated position. Blood samples were drawn from the antecubital
vein for biochemistry study. This study was approved by the
institutional review board of the M J Life Clinic. All participants had
given informed consent.2.2. Laboratory measurement
Plasma was separated from blood within 1 hour after blood
being drawn, and then was stored at a temperature of e30C until
analysis. The samples are analyzed for plasma glucose and lipid
levels.
Plasma glucose was examined with a glucose oxidase method
(YSI 203 glucose analyzer, Scientiﬁc Division, Yellow Spring
Instrument Company, Yellow Spring, OH, USA). Triglyceride (TG)
and total cholesterol (TC) were measured with the dry, multilayer
analytical slide method in the Fuji Dri-Chem 3000 analyzer (Fuji
Photo Film, Minato-Ku, Tokyo, Japan). Serum high-density lipo-
protein cholesterol (HDL-C) and low-density lipoprotein choles-
terol (LDL-C) concentrations were measured using an enzymatic
cholesterol assay following dextran sulfate precipitation. The PC
was measured with an Abbott Cell Dyn 3000 hematology analyzer
(Abbott Laboratories, Abbott Park, IL, USA).
2.3. Statistical analysis
The data were analyzed with SPSS version 13.0 (SPSS, Chicago,
IL, USA). All data were tested for normal distribution with
KolmogoroveSmirnov test and for homogeneity of variances with
Levene’s test. Continuous variables are expressed as mean 
standard deviation (SD). The t test was used to evaluate the
differences between two groups. When comparing the differences
between three groups, one-way analysis of variance (ANOVA) was
used. For post hoc comparison, the Bonferroni test was applied. To
observe the correlation between different parameters, simple
correlation and multivariate linear regression were used. Finally,
the odds ratio (OR) was calculated to compare the possibilities of
having MetS in different groups. Among all the parameters, TG is
not normally distributed; log transformation (Log-TG) was per-
formed before further analysis.
All statistical tests were two sided and considered statistically
signiﬁcant when p < 0.05.
3. Results
Among the 1187 participants, 301 had MetS (MetSþ group). The
anthropometric variables, biochemistries, and PC are shown in
Table 1. There was no signiﬁcant difference between TC13, LDL-C,
and PC in patients with and without MetS (MetSþ and MetSe,
respectively). On the other hand, not surprisingly, MetSþ group
had signiﬁcantly higher age, BMI, systolic blood pressure (SBP),
diastolic blood pressure (DBP), fasting plasma glucose (FPG),
HDL-C, and log-TG than MetSe group.
Table 2
MetS components according to PLTC (mean  SD).
PLT 1 PLT 2 PLT 3 PLT 4 p
Number 286 307 304 290
PLTC (103/mL) 143.6  4.2 182.8  8.7 214.9  10.2 274.7  42.8 0.000
Age (y) 70.6  4.2 70.4  4.7 70.3  4.5 69.8  4.5 0.180
BMI (kg/m2) 19.3  2.6 19.5  2.6 19.5  2.6 19.1  2.4 0.170
SBP (mmHg) 133.6  21.6 136.0  21.5 134.2  19.8 136.4  21.4 0.304
DBP (mmHg) 75.3  11.6 77.6  12.5 75.5  11.5 76.2  11.6 0.069
FPG (mmol/L) 102.5  21.9 107.5  24.1 105.0  25.8 109.6  35.7 0.012
TC (mmol/L) 193.9  37.5a,b,c 204.5  37.2d 208.7  37.5d 210.0  40.2d 0.000
HDL-C (mmol/L) 45.4  12.8 45.5  13.2 47.0  14.3 46.6  15.3 0.361
LDL-C (mmol/L) 127.0  33.2b,c 133.8  32.2 136.3  35.0d 137.8  35.7d 0.001
TG (mmol/L) 107.8  54.3a,b,c 125.9  65.8d 127.3  68.3d 128.3  62.5d 0.000
Log-TG 2.0  0.2 2.0  0.2 2.1  0.2 2.1  0.2 0.000
BMI ¼ body mass index; DBP ¼ diastolic blood pressure; FPG ¼ fasting plasma glucose; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipoprotein
cholesterol; Log-TG ¼ log transformation of triglyceride; MetS ¼ metabolic syndrome; PLT ¼ platelet; PLTC ¼ platelet count; SBP ¼ systolic blood pressure; TC ¼ total
cholesterol; TG ¼ triglyceride.
a p < 0.05 against PLTC2.
b p < 0.05 against PLTC3
c p < 0.05 against PLTC4.
d p < 0.05 against PLTC1.
Platelet Count in Metabolic Syndrome 217The participants were further divided into quartiles according to
the PC arbitrarily (PC1ePC4, according to lowest to highest PCs).
Thus, we can further evaluate the differences of MetS components
between these four groups. Table 2 shows the MetS components
among these four groups. Fig. 1 demonstrates their relationship
graphically, which depicts that higher PC could be noted in
participants with more MetS components. Conversely, Fig. 2
showed their opposite relationship, i.e., the numbers of MetS
components in different PC groups. In general, TC, LDL-C, and TG
were lower in the PC1 group compared to the other three groups. At
the same time, the FPG level only in the PC1 group was lower than
in the PC4 group. No signiﬁcant differences could be noted in other
components between the four groups.
The results of simple correlation between PC and each MS
component were shown in Table 3. Compatible with the results of
ANOVA, FPG, TC, LDL-C, and TG were signiﬁcantly related to PC.
Finally, these signiﬁcantly related components were further put
into multiple regression to determine their effects independently.
It showed that FPG, LDL-C, and TG were still positively related to
PC (Table 4). By using the logistic regression, we found that all
the other three groups had signiﬁcantly higher OR to havePlatelet count group
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Fig. 1. Platelet count groups and metabolic syndrome components. PC1ePC4: groups
of individuals with different platelet counts from the lowest quartile to the highest
(PC1 to PC4, respectively).MetS than PC1 (1.221, 0.826e1.805; 1.323, 0.902e1.940; 1.587,
1.090e2.310dORs and 95% CI for PC2, PC3, and PC4, respectively;
Fig. 3).
4. Discussion
The aim of this study was to investigate the relationships
between PC and MetS components in geriatric Taiwanese males. Of
note, both age and BMI were similar in the four groups, with
different PC. This is beyond our expectation since higher age and
BMI were expected in PLT4. The homogeneity of our study pop-
ulation in the four groups increased the strength of our results. In
terms of the relationships between PC andMetS, therewere several
studies focusing on this topic previously. For example, Jesri et al25
had found elevated PC in 135 volunteers with MetS. Similar result
was also found in middle-aged Japanese females26. In general, our
results were similar to these two studies. However, to our knowl-
edge, our study is the ﬁrst one to focus on geriatric men. Other than
this, the relationship between LDL-C and PC was surprising and
worth further discussion.
The ﬁrst interesting ﬁnding was the positive correlation
between PC and FPG. This relationship remained signiﬁcant even
after themultiple regressionwas performed. Similar result was also
found in 1314 Thais. In their study, the correlation coefﬁcientMetabolic syndrome components number
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Fig. 2. Metabolic syndrome components and platelet counts.
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Fig. 3. Odds ratio for participants in different PC groups to have metabolic syndrome.
PC ¼ platelet count group.
Table 3
Simple correlation of PCs and each MetS components.
r p
BMI (kg/m2) 0.047 0.103
SBP (mmHg) 0.031 0.285
DBP (mmHg) 0.017 0.561
FPG (mmol/L) 0.101 0.000
TC (mmol/L) 0.147 0.000
HDL-C (mmol/L) 0.039 0.177
LDL-C (mmol/L) 0.114 0.000
TG (mmol/L) 0.099 0.001
BMI ¼ body mass index; DBP ¼ diastolic blood pressure; FPG ¼ fasting plasma
glucose; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipo-
protein cholesterol; MetS¼metabolic syndrome; PC¼ platelet count; SBP¼ systolic
blood pressure; TC ¼ total cholesterol; TG ¼ triglyceride.
Y.-L. Chang et al.218between PC and FPG was 0.099 in male and 0.088 in female27.
Theoretically, FPG should be related to PC since elevated plasma
glucose level has been shown to be a prothrombotic condition28. In
addition, higher plasma glucose level also enhances platelet
activity29. Multiple mechanisms were involved in this process, and
it had been shown to be mediated via superoxide anion production
and protein kinase C signaling30. In a similar study done by our
group in a younger cohort (age between 44 and 51 years), the
relationship between WBC and FPG was not signiﬁcant31. It is
probably because the FPG level is the ﬁnal result of the interaction
between insulin action (insulin sensitivity) and secretion. The
emergence of its signiﬁcance in the present study suggested that
the ability of insulin secretion deteriorates in older individuals.
Thus, FPG reﬂects directly the effect of insulin resistance since the
compensation ability of beta-cell decreases. This is a novice ﬁnding
in our study.
It is interesting to note that although HDL-C is one of the criteria
of the NCEP deﬁnition. However, in our study, instead of the
expected negative correlation between PC and HLD-C, positive
correlations between PC and both TC and LDL-C were found. Again,
this correlation continued to exist even after the effects of FPG and
TG were removed by the multiple regression model. This is a new
ﬁnding, which has never been reported before. Similar results had
been found in a younger Japanese cohort (age between 51 and 53
years); LDL-C level was found to be correlated to the number of
MetS32. This ﬁnding could be explained by thewell-known fact that
increased LDL-C level plays a role in vascular inﬂammation33,34 and
platelet activity35,36. Compared to the important role of CRP, the
relationship between PC and LDL-C seemed less impressive. It
would be interesting to know whether this relationship is inde-
pendent of CPR or not. Unfortunately, we did not measure CRP level
in this study. Still, our results give rise to the question that whether
LDL-C should replace HDL-C as one of the criteria of MetS in the
elderly.
Other than FPG and LDL-C, TG level was also positively corre-
lated with PC after the multiple regression. According to what we
have explained as the possible mechanisms of the relationship
between PC and inﬂammation in the previous paragraph, this
ﬁnding was not surprising. Other inﬂammatory markers were also
proved to have a relationship with PC. For example, interleukin-6Table 4
Multiple regression of PCs and MetS components.
b p
FPG (mmol/L) 0.075 0.011
LDL-C (mmol/L) 0.102 0.000
TG (mmol/L) 0.075 0.011
FPG ¼ fasting plasma glucose; LDL-C ¼ low-density lipoprotein cholesterol;
MetS ¼ metabolic syndrome; PC ¼ platelet count; TG ¼ triglyceride.was found to be associated with increased PC by stimulating
thrombopoiesis through thromboproietin37,38. In addition, tumor
necrosis factor-awas also found to be related to TG both in vivo and
in vitro39,40. All these data helped substantiate our ﬁndings.
Although other studies reported similar results, it should be
stressed that our study was the ﬁrst one to be done in the elderly.
Finally, it is interesting to note that PC had no correlation with
BMI and BP, which was expected. Theoretically, both of them were
known to be correlated with inﬂammation33,41. However, in the
meantime, there are limited data focusing on these particular
relationships in the literature. In the ASCOT (Anglo-Scandinavian
Cardiac Outcomes Trial) study, Spencer et al42 showed that the PC
was not higher in individuals with hypertension. In that study,
although the mean age was similar to our study, it should be noted
that most of the study participants were on antihypertensive drugs
(89%). Therefore, it would be difﬁcult to observe the real relation-
ship between BP and PC. The nonsigniﬁcant correlation between PC
and BP in our study implied that among the ﬁve components, BP
might have a different pathophysiology from others. This theory
could be supported by our previously published paper suggesting
that BP did not cluster with other MetS components and insulin
resistance43. Secondly, the relationship between BMI and PC was
also nonsigniﬁcant in this study. Since both PC and adiposity were
known to be related to inﬂammation37,38,44, this ﬁnding was
surprising and contrary to most of the other studies. However, it is
interesting to note that although patients with MetS had higher
BMI (Table 1), this difference disappeared after they were divided
into four groups according to the PC (Table 2). Even in the simple
correlation, the r value between BMI and PC was only 0.047
(Table 3). The relatively low BMI (around 19.1e19.5 kg/m2) in our
study was an important characteristic and might explain this
paradox. The narrow range of the BMI might attenuate the statis-
tical signiﬁcance. Further study with wilder range of BMI might be
needed to elucidate their relationship in other geriatric groups.
Several limitations were noted in this study. First, this was only
a cross-sectional study that provides less information than
a longitudinal study. Second, there was no plasma insulin level
available. Thus, the evaluation of the insulin resistance, the core of
MetS, was not possible. Further study focusing on the relationship
between insulin resistance and PC would be both interesting and
important.
Platelet Count in Metabolic Syndrome 219In conclusion, PC was found to be positively correlated to LDL-C,
TG, and FPG in geriatric males. Our data suggest that LDL-C should
be considered as one of the MetS components instead of HLD-C in
this age group. Moreover, the important role of PC in MetS should
also be stressed.
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